about
Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptabilityEmerging and investigational drugs for premature ejaculationSperm chromosomal aneuploidy and DNA integrity of infertile men with anejaculationBenign prostatic hyperplasia: from bench to clinicA meta-analysis of efficacy and safety of the new α1A-adrenoceptor-selective antagonist silodosin for treating lower urinary tract symptoms associated with BPH.Silodosin in the treatment of benign prostatic hyperplasiaSafety and efficacy of silodosin for the treatment of benign prostatic hyperplasiaTamsulosin MR and OCAS (modified release and oral controlled absorption system): current therapeutic uses.Subtypes of alpha1-adrenoceptors in BPH: future prospects for personalized medicine.Silodosin : a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia.Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates.Management of benign prostatic hyperplasia with silodosinIloperidone-induced ejaculatory dysfunction: A case series.Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy.Effectiveness and safety of silodosin in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia: A European phase IV clinical study (SiRE study).Randomized crossover comparison of tamsulosin and alfuzosin in patients with urinary disturbances caused by benign prostatic hyperplasia.Regulation of nerve-evoked contractions of rabbit vas deferens by acetylcholine.Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH.Effects of Silodosin and Tamsulosin on the Seminal Vesicle Contractile Response.Emerging drugs for the treatment of benign prostatic hyperplasia.Efficacy and safety of orally disintegrating tamsulosin tablets in Taiwanese patients with benign prostatic hyperplasia
P2860
Q26823762-2505284C-9B13-45EC-8A5A-DC61C2E389ECQ28078002-A799A7B4-68DC-44A5-ABA1-BBCC5D2239F2Q28732282-7CCEECCD-61D6-47E4-A8CB-CE690DE69383Q34216723-EA64FD99-51E3-4B27-B400-32268C13C278Q34417223-B4F5690E-6AFB-4E38-940E-04034250A372Q34625490-9CDC385A-172E-44E1-9CC9-30D9FDA2483DQ34630995-E87D6698-E274-484C-9073-8527C39E46D5Q37111860-6264C6D4-8DA6-410F-AD70-8DA86381340FQ37365172-FF31C27C-27E6-4686-9338-B72AE8411457Q38038271-60356466-6A81-4078-90E5-E424FD1D85D8Q38081486-22CFE300-714E-4B49-8503-1760651B555CQ38160469-18173F92-FD2A-4D58-972E-363B41D277F7Q38751621-7CDD9627-061B-40E5-9B76-6CAA8D2BE94CQ38764304-37691D68-C89C-42F9-B794-6EC40292F8BBQ39926524-210C6010-F4BE-44FA-8FC8-F7DF062F4ED6Q39978281-4DBCFB52-1DFB-415B-B51E-FF0442039425Q40550773-1F127206-878F-41C4-9AB6-F6E53A3F13B9Q41922883-6B2E6283-8A8A-4964-8C04-6D5871DEEDB5Q46637526-AC892FED-B6BE-4CBC-A897-F76CC6CEB99BQ47553287-2E4210C4-7775-4BE3-979E-47151EB03B48Q58283335-270FB892-AE0E-4F62-AD62-F9EE90A9D81E
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Alpha1-adrenoceptors and ejaculatory function.
@ast
Alpha1-adrenoceptors and ejaculatory function.
@en
type
label
Alpha1-adrenoceptors and ejaculatory function.
@ast
Alpha1-adrenoceptors and ejaculatory function.
@en
prefLabel
Alpha1-adrenoceptors and ejaculatory function.
@ast
Alpha1-adrenoceptors and ejaculatory function.
@en
P2860
P356
P1476
Alpha1-adrenoceptors and ejaculatory function.
@en
P2093
M C Michel
P2860
P304
P356
10.1038/SJ.BJP.0707369
P407
P577
2007-07-02T00:00:00Z